Key Insights

Highlights

Treatment Research

1 treatments under study, led by Serum Pai1 Alpha Analysis

Related Conditions

Often studied with 8 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Unknown1
Active Not Recruiting1

Clinical Trials (2)

Showing 2 of 2 trials
NCT07051408Active Not Recruiting

Predictors Of Cognitive Decline Using Digital Devices

NCT04997928Unknown

PAI-1 Levels and Predicting Covid-19 Patients' Prognosis

Showing all 2 trials

Research Network

Common Treatments

  • Serum Pai1 Alpha Analysis1

Active Sponsors

  • University Of Oxford1
  • Saglik Bilimleri Universitesi1
  • University College London1

Related Conditions

  • Covid19 Positivity Confirmed With Pcr Positivity In The Nasopharyngeal Swab1
  • Mild Cognitive Impairment Mci1
  • Patients Among 20 To 90 Years Of Age1
  • Subjective Cognitive Decline Scd1
  • Patients Who Did Not Vaccinate Against Covid191

Activity Timeline